Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
Titel:
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
Auteur:
Castellano, D. del Muro, X. Garcia Pérez-Gracia, J.L. González-Larriba, J.L. Abrio, M.V. Ruiz, M.A. Pardo, A. Guzmán, C. Cerezo, S. Díaz Grande, E.